FDA Public Health Advisory: Suicidality With Antidepressant Medications
Jim Vititoe | October 14, 2004
Today the Food and Drug Administration (FDA) directed manufacturers of all antidepressant drugs to revise the labeling for their products to include a boxed warning and expanded warning statements that alert health care providers to an increased risk of suicidality (suicidal thinking and behavior) in children and adolescents being treated with these agents, and to [...]